Improving Salmonella vector with recmutation to stabilize the DNA cargoes
© Zhang et al; licensee BioMed Central Ltd. 2011
Received: 4 November 2010
Accepted: 8 February 2011
Published: 8 February 2011
Salmonella has been employed to deliver therapeutic molecules against cancer and infectious diseases. As the carrier for target gene(s), the cargo plasmid should be stable in the bacterial vector. Plasmid recombination has been reduced in E. coli by mutating several genes including the recA, recE, recF and recJ. However, to our knowledge, there have been no published studies of the effect of these or any other genes that play a role in plasmid recombination in Salmonella enterica.
The effect of recA, recF and recJ deletions on DNA recombination was examined in three serotypes of Salmonella enterica. We found that (1) intraplasmid recombination between direct duplications was RecF-independent in Typhimurium and Paratyphi A, but could be significantly reduced in Typhi by a ΔrecA or ΔrecF mutation; (2) in all three Salmonella serotypes, both ΔrecA and ΔrecF mutations reduced intraplasmid recombination when a 1041 bp intervening sequence was present between the duplications; (3) ΔrecA and ΔrecF mutations resulted in lower frequencies of interplasmid recombination in Typhimurium and Paratyphi A, but not in Typhi; (4) in some cases, a ΔrecJ mutation could reduce plasmid recombination but was less effective than ΔrecA and ΔrecF mutations. We also examined chromosome-related recombination. The frequencies of intrachromosomal recombination and plasmid integration into the chromosome were 2 and 3 logs lower than plasmid recombination frequencies in Rec+ strains. A ΔrecA mutation reduced both intrachromosomal recombination and plasmid integration frequencies.
The ΔrecA and ΔrecF mutations can reduce plasmid recombination frequencies in Salmonella enterica, but the effect can vary between serovars. This information will be useful for developing Salmonella delivery vectors able to stably maintain plasmid cargoes for vaccine development and gene therapy.
Attenuated Salmonella are being developed as vaccines to protect against typhoid fever [1–3]. There are also endeavors employing Salmonella as delivery vectors for therapeutic molecules. One strategy utilizes attenuated Salmonella, which expresses a gene or gene fragment encoding a protective antigen as vaccine against bacterial pathogens [4–6]. The heterologous genes can be expressed from the Salmonella chromosome, or, more often, from a multi-copy plasmid [7, 8]. Another strategy exploits Salmonella as a delivery vector of DNA vaccine against viral pathogens [4, 5, 9]. The later strategy is also used to deliver DNA encoding tumor antigen or cytokine for therapeutic applications in oncology [10, 11]. In addition, Salmonella is used to deliver small interfering RNAs (siRNA) , ribozymes  and large DNA molecules encoding a viral genome . For instance, in vivo delivery of an artificial bacterial chromosome (BAC) carrying the viral genome of the murine cytomegalovrirus (MCMV) by Salmonella Typhimurium led to a productive virus infection in mice and resulted in elevated titers of specific antibodies against lethal MCMV challenge .
Most vaccine designs utilize Salmonella delivery vectors carrying a single plasmid for expression of a single antigen or of a fusion protein carrying epitopes from more than one antigen . To induce broader immunity against a particular pathogen or various pathogens, one might need to express multiple antigens from a single plasmid carrying different antigen cassettes or from multiple plasmids in a single cell, each expressing one or more relevant antigens. Co-delivery of plasmids encoding tumor antigens and cytokines by Salmonella has been successfully demonstrated to improve protective immunity against cancer . In the case where multiple plasmids are carried in the same Salmonella vector strain, there are most likely regions of homology between the plasmids, since the widely used pUC- and pBR-based plasmids have origins of replication that are nearly identical and both share regions of homology with the p15A ori. Additionally, commonly used promoter sequences, transcriptonal terminators and other expression plasmid components may also be present on plasmids coexisting in the same bacterial cell. The presence of these similar or identical DNA sequences would serve to facilitate undesirable interplasmid recombination. In some cases the bacterial vector may intentionally harbor multiple copies of the same DNA sequence, which may lead to plasmid instability. Recently, we encountered such a situation during the development of a bacterial based influenza vaccine. We constructed a single plasmid carrying eight head-to-tail connected influenza cDNA cassettes . The plasmid was intended for delivery into host cells by an attenuated Salmonella strain. The multiple repetitive sequences residing in the plasmid make its stability within the attenuated Salmonella an important concern because any intraplasmid recombination event results in deletion of one or more influenza gene cassettes.
Recent work in our laboratory has focused on developing new strategies for attenuated Salmonella vaccine strains, with features including regulated delayed in vivo attenuation [18, 19], regulated delayed in vivo antigen synthesis [18, 20–22], and programmed delayed in vivo cell lysis [23, 24]. For all of these systems, one or more chromosomal and/or plasmid genes are placed under the control of the araC PBAD promoter. Eventually, our goal is to combine all of these features into a single Salmonella vaccine vector strain. Such a strain will therefore carry multiple chromosomal and plasmid copies of araC PBAD, providing sites for potential recombination, which could lead to unwanted chromosomal or plasmid rearrangements.
However, to our knowledge, there have been no published studies specifically designed to evaluate plasmid recombination in Salmonella enterica. Deletions of several Escherichia coli genes are known to reduce the frequency of plasmid recombination, including the recA, recE, recF and recJ genes [25–30]. The recA gene encodes the general recombinase RecA, involved in nearly all forms of recombination in the cell . The RecE, RecF and RecJ proteins play a role in plasmid recombination and recombination repair [32, 33]. The RecA, RecF and RecJ proteins are highly homologous between E. coli and S. enterica, therefore they may play similar roles in DNA recombination. Despite these possible similarities, the recombination systems in the two organisms differ somewhat, as S. enterica does not encode recE . Based on these concerns, we decided to determine the effect of rec gene deletions on intraplasmid recombination, interplasmid recombination, intrachromosomal recombination and plasmid integration in S. enterica.
In this work, we examine the effect of ΔrecA, ΔrecF and ΔrecJ mutations on DNA recombination frequencies in three serovars of Salmonella enterica currently relevant to vaccine development. Our results show that the effect of these mutations on recombination can vary among Salmonella serovars and with previously published results in E. coli.
Plasmids used in this study
Reference or source
cat, tetA, p15A ori
amp, pBR ori
λ Red recombinase expression plasmid
cat, kan, p15A ori
pACYC184, adjacent 5'tet and 3'tet
oriT, oriV, sacB, cat
pYA4464, cat, p15A ori, GFP gene
Two cysG fragments
aacC1, pSC101 ori, T vector
pYA5001, recA cassette from Typhimurium χ3761
pYA5001, recA cassette from Typhi Ty2 χ3769
pYA5001, recF gene from Typhimurium χ3761
pYA5001, recF gene from Typhi Ty2 χ3769
Plasmids pYA4463 and pYA4590 were constructed to test intraplasmid recombination (Figure 1 panel A). Plasmid pYA4463 carries two truncated tetA genes (5' end and 3'end), which have 466-bp of tandemly repeated sequence. An intramolecular recombination event can delete one of the repeats resulting in an intact tetA gene, thereby recreating the structure of plasmid pACYC184 (Figure 1 panel A). Theoretically, intermolecular recombination may occur between two pYA4463 molecules to form a plasmid dimer with a functional tetA gene (Figure 1 panel C). Plasmid pYA4590 contains a 602-bp tetA sequence duplication separated by a 1041-bp kan cassette. The intramolecular recombination product is equivalent to pACYC184. The intermolecular recombination product is a dimer plasmid containing an intact tetA gene (Figure 1 panel C). Plasmids pYA4464 and pYA4465 carry the 3'tet gene and 5'tet gene, respectively (Figure 1). The Rec+ Salmonella strain χ3761 carrying either plasmid individually was sensitive to tetracycline. There is 751-bp of tetA DNA in common between the two truncated tetA genes. Recombination between the two plasmids creates a hybrid plasmid containing an intact tetA gene (Figure 1 panel C).
Intraplasmid recombination products
Plasmids extracted from TcR clones of χ3761(pYA4590) were digested with KpnI and EcoRI. Theoretically, plasmid pYA4590 will be digested into two fragments (3414 bp and 2474 bp), plasmid pACYC184 will be linearized (4245 bp) and the pYA4590 plasmid dimer will be digested into four fragments (4245 bp, 3414 bp, 2474 bp and 1643 bp). Examination of the restricted DNA (Figure 3B) showed that only one clone (lane 12) had the pYA4590 dimer-specific 1643-bp band. The most prominent band in the other lanes was a 4245-bp band expected for pACYC184-like recombination products. Nine clones contained a mixture of pACYC184 and pYA4590 (lane 1, 3-5, 8, 9, 14-16).
Interplasmid recombination products
Plasmids extracted from TcR clones of χ3761(pYA4464, pYA4465) were digested with NcoI and BglII. Both pYA4464 and pYA4465 are linearized into a DNA fragment about 4 kb. Therefore, in cells containing each or both monomeric plasmids, the digested product will be a single band. The pYA4464-pYA4465 hybrid will be cut into two fragments (5510 bp and 2481 bp). All four of the TcR clones we isolated and examined showed recombination product specific bands and the 4-kb band expected when each plasmid exists separately in the cell. Four tetracycline sensitive (TcS) isolates were examined and only a single band was observed, as expected (Figure 3C). These results suggest that interplasmid recombination occurred in the TcR cells and that both dimer and individual monomers corresponding to at least one of the two starting plasmids can coexist in the same bacterial cell. We performed a similar experiment in S. Typhi strain Ty2(pYA4464, pYA4465) and obtained identical results (data not shown).
Construction of recdeletion strains
The bacterial strains used in this study
Genotype* [parental strain]
Reference or source
S. Typhimurium UK-1
ΔrecJ1315 ΔrecF126 [χ9072]
ΔrecF126 cysG494::(5'tet-kan-3'tet) [χ9070]
ΔrecJ1315 cysG494::(5'tet-kan-3'tet) [χ9072]
ΔrecA62 cysG494::(5'tet-kan-3'tet) [χ9833]
ΔrecF126 cysG493::(5'tet-kan) [χ9070]
ΔrecJ1315 cysG493::(5'tet-kan) [χ9072]
ΔrecA62 cysG493::(5'tet-kan) [χ9833]
ΔrecF126 Δ recA62 [χ9070]
S. Typhi Ty2
S. Typhi ISP1820
S. Paratyphi A
Plasmid pSPA1 was cured from wt isolate ATCC 9281
E. coli K-12
F- mcrA Δ (mrr-hsdRMS-mcrBC) Φ80dlacZ Δ M15 Δ lacX74 recA1 endA1 araD139 Δ (ara, leu)7697 galU galK λ- rpsL nupG trfA dhfr
thi-1 thr-1 leuB6 glnV44 fhuA21 lacY1 recA1 RP4-2-Tc::Muλpir ΔasdA4 Δzhf-2::Tn10
Effect of recdeletions on intraplasmid recombination
Plasmid recombination frequency (Mean ± STD, × 10-3)
1.55 ± 0.31
2.40 ± 0.54
2.88 ± 0.85
1.07 ± 0.24
0.22 ± 0.07**
0.27 ± 0.07**
1.14 ± 0.15
0.52 ± 0.07**
0.33 ± 0.09**
1.87 ± 0.44
2.37 ± 0.21
1.10 ± 0.20**
0.35 ± 0.08**
0.41 ± 0.09**
0.35 ± 0.08**
2.50 ± 0.42
2.00 ± 0.24
S. Typhi Ty2
4.69 ± 0.26
11.59 ± 2.61
4.20 ± 1.44
1.32 ± 0.27**
0.60 ± 0.19**
3.37 ± 0.96
0.51 ± 0.06**
0.57 ± 0.09**
6.19 ± 2.71
0.45 ± 0.05**
0.52 ± 0.17**
16.28 ± 2.64**
1.69 ± 0.26**
4.88 ± 1.56**
2.31 ± 0.90
2.52 ± 0.18
1.71 ± 0.68
14.35 ± 2.44
2.86 ± 0.59
S. Typhi ISP1820
4.93 ± 0.67
13.10 ± 1.23
4.22 ± 0.25
0.65 ± 0.26**
0.71 ± 0.06**
5.38 ± 0.58
S. Paratyphi A
2.70 ± 0.39
3.32 ± 0.61
1.03 ± 0.15
1.91 ± 0.69**
0.55 ± 0.20**
0.13 ± 0.03**
5.00 ± 0.70
1.16 ± 0.21**
0.34 ± 0.04**
2.56 ± 0.41
1.83 ± 0.99**
0.64 ± 0.15**
The results with plasmid pYA4590 were also variable among strains. The recombination frequency in Rec+ S. Typhimurium and S. Paratyphi A strains was approximately 2-3 × 10-3 and in both S. Typhi strains, the frequency was 3-fold higher, at 1.16 × 10-2 (Ty2) and 1.31 × 10-2 (ISP1820). In S. Typhimurium and S. Typhi Ty2, the Δ recA and ΔrecF mutations reduced the recombination frequency of plasmid pYA4590 by 5-20-fold (P < 0.01; Table 3). The results were similar for S. Paratyphi A, though the ΔrecF mutation only led to 3-fold lower plasmid pYA4590 recombination (P < 0.01). The ΔrecJ mutation had no effect in S. Typhimurium and resulted in a 2-3-fold decrease in recombination in both S. Typhi Ty2 and S. Paratyphi A. Combining the ΔrecA ΔrecF mutations in S. Typhimurium led to a recombination frequency similar to the frequencies observed for both mutations individually, indicating no additive effect. In the complementation test, plasmid pYA5002, which encodes S. Typhimurium recA, was transformed into S. Typhimurium ΔrecA mutant χ9833(pYA4590) and S. Typhi ΔrecA mutant χ11159(pYA4590). Their respective recombination frequencies were 2.50 ± 0.42 × 10-3 and 14.35 ± 2.44 × 10-3, which were comparable to the corresponding wild type strains (P > 0.05) (Table 3). The recF-encoding plasmids pYA5005 and pYA5006 were transformed into recF mutant strains χ9070(pYA4590) and χ11053(pYA4590), respectively. The respective recombination frequencies were increased to 2.00 ± 0.24 × 10-3 and 2.86 ± 0.59 × 10-3.
Effect of recdeletions on interplasmid recombination
To evaluate interplasmid recombination, plasmids pYA4464 and pYA4465 were co-electroporated into the wild-type and rec deletion strains. Electroporants from each test strain were grown in LB broth containing both ampicillin and chloramphenicol to maintain selection for both plasmids. The frequency of recombination was determined as described in the Methods section. The interplasmid recombination frequency was 1-4 × 10-3 for Rec+ S. Typhimurium, S. Typhi and S. Paratyphi A strains (Table 3). For Typhimurium and Paratyphi A, the ΔrecA and each ΔrecF mutation reduced the interplasmid recombination frequency by about 3-10-fold (P < 0.01). In contrast, the ΔrecA mutation had no effect on interplasmid recombination in S. Typhi Ty2. The ΔrecF mutations did not reduce interplasmid recombination in either of the Typhi strains. Surprisingly, introduction of the ΔrecF1074 mutation into S. Typhi Ty2 resulted in significantly higher interplasmid recombination (P < 0.01). Note that we performed this analysis in eight independent experiments and observed a higher recombination frequency of interplasmid recombination each time. The ΔrecJ mutation had no significant effect in S. Typhi, and a small (< 3-fold) but significant effect in S. Typhimurium and S. Paratyphi A. The recombination frequencies were also determined in S. Typhimurium strains ΔrecA ΔrecF and ΔrecF ΔrecJ double deletions. No additive effect between the two mutations was observed with respect to each single mutation.
Effect of recdeletions on chromosome related recombination
Chromosome related recombination in S. Typhimuriuma
6.02 ± 0.38
5.59 ± 0.94
7.05 ± 1.40
2.13 ± 0.60**
9.18 ± 2.18
4.89 ± 0.41
1.29 ± 0.51**
To examine plasmid integration, the 5'tet gene was introduced into the S. Typhimurium chromosome at cysG. The resulting strains were transformed with plasmid pYA4464 (3'tet) (Figure 1B). The 789 bp of overlapping sequence between 5'tet on the chromosome and the 3'tet on the plasmid could result in plasmid integration into the chromosome, generating an intact tetA gene (Figure 2B). Deletion of recA had a profound effect, reducing the integration frequency to less than 7 × 10-10, which was below the limits of detection in this assay (P < 0.01), indicating a strict requirement for RecA in this process. Introduction of plasmid pKD46, which encodes the λ Red recombinase, into χ9938 (ΔrecA) carrying pYA4464 restored the integration frequency to the level of the Rec+ strain χ9935. Deletion of recF reduced the frequency of integration less than 3-fold (P < 0.01; Table 4) and the ΔrecJ deletion had no effect.
Effect of rec deletions on the virulence of S. Typhimurium
Virulence of S. Typhimurium rec mutants in BALB/c mice (oral inoculation)
1.5 × 106
3.2 × 104
1.5 × 105
1.5 × 104
1.5 × 103
1.0 × 107
6.8 × 104
1.0 × 106
1.0 × 105
1.0 × 104
1.0 × 107
1.5 × 105
1.0 × 106
1.0 × 105
1.0 × 104
ΔrecJ1315 Δ recF126
1.0 × 107
2.2 × 106
1.0 × 106
1.0 × 105
1.0 × 104
1.3 × 109
>1.3 × 109
We began our studies using information gathered in E. coli as a reference point. In E. coli, recA-dependent homologous recombination relies on the RecBCD pathway, the RecFOR pathway (originally designated the RecF pathway) and the RecE pathway . The RecBCD pathway is important in conjugational and transductional recombination , and may also be involved in the recombination of plasmids containing one or more Chi sites . Recombination in small plasmids lacking a Chi sequence is primarily catalyzed by the RecFOR pathway . RecF, RecO, and RecR bind to gaps of ssDNA and displace the single-strand DNA binding proteins to allow RecA to bind [42, 43]. The RecJ ssDNA exonuclease acts in concert with RecFOR to enlarge the ssDNA region when needed. Strand exchange is then catalyzed by RecA . Because of their prominent role in plasmid recombination in E. coli, we analyzed the effect of mutations in recF, recJ and recA on plasmid recombination in Salmonella.
Attenuated S. Typhi strains have been developed as antigen delivery vectors for human vaccine use. Due to the host restriction phenotype of S. Typhi, preliminary work is typically done in S. Typhimurium using mice as the model system to work out attenuation and antigen expression strategies. Recently, we have also been investigating attenuated derivatives of the host-restricted strain S. Paratyphi A as a human vaccine vector. Therefore, it was of interest to evaluate and compare the effects of rec mutations in these three Salmonella serovars. We selected S. Typhi strain Ty2 as exemplary of this serovar because most of the vaccines tested in clinical trials to date have been derived from this strain . S. Typhi strain ISP1820 has also been evaluated in clinical trials [46, 47] and we therefore included it in some of our analyses. We found that, for some DNA substrates, the effects of ΔrecA and ΔrecF deletion mutations differed among Salmonella enterica serotypes. In particular, we found that deleting recA, recF or recJ in S. Typhi Ty2 and deleting recF in strain ISP1820 had significant effects (3-10 fold) on the recombination frequency of our direct repeat substrate, pYA4463 (Table 3). No or very limited effect (< 2 fold) was observed for our S. Typhimurium and S. Paratyphi A strains, consistent with results reported for E. coli indicating that recombination of this type of substrate is recA-independent . In contrast, the ΔrecA and ΔrecF mutations resulted in lower interplasmid recombination in Typhimurium and Paratyphi A but not in Typhi strains. Deletion of recJ led to a reduction in intraplasmid recombination frequencies in S. Typhi, while no effect was seen in S. Typhimurium. The ΔrecJ mutation also affected plasmid recombination frequencies for two of the three substrates tested in S. Paratyphi A. Taken together, these results suggest that the recombination system in S. Typhi, or at least in strains Ty2 and ISP1820, is not identical to the recombination system in S. Typhimurium and S. Paratyphi A.
To investigate the mechanism responsible for the observed differences, we analyzed the genome sequences of S. Typhimurium UK-1 (Luo, Kong, Golden and Curtiss, unpublished whole genome sequence), S. Paratyphi A (NC_006511)  and S. Typhi Ty2 (NC_004631) . No paralogs of the recA, recF and recJ genes were found in the three strains. The S. Typhimurium UK-1 has RecA, RecO and RecR protein sequences identical to Typhi Ty2, and RecF and RecJ protein sequences with over 99% identity. Plasmids expressing Typhimurium recF or Typhi recF complemented the ΔrecF126 mutation in Typhi, as evidenced by the UV sensitivity profile (Figure 4) and intraplasmid recombination of pYA4463 (Table 3). Therefore, the basis for these differences are not clear and indicates that there may be other genes or gene products involved. A more detailed analysis of this phenomenon is under investigation.
Plasmid recombination frequencies were higher in our Salmonella strains than those reported in E. coli. We observed intra- and interplasmid recombination frequencies on the order of 1 × 10-3 in Rec+ Salmonella, whereas measurements made in E. coli strain AB1157 using a similar plasmid system (equivalent to our substrates pYA4590 and pYA4464 + pYA4465) revealed a basal frequency around 10-fold lower, approximately 1 × 10-4 for both types of substrates . Interestingly, the effect of a recF mutation in E. coli was to reduce the recombination frequency of intra- and interplasmid recombination approximately 30-fold, to roughly the same frequencies we observed for S. Typhimurium (Table 3). However, consistent with the results in E. coli, the effects of recA, recF, and recA recF mutations were similar, indicating that the mutations are epistatic.
RecF has been shown previously to play a role in recombinational repair of chromosomal DNA in response to DNA damaging agents , including a major role in homologous recombination between direct repeats in the chromosome of S. Typhimurium. In our study, we did not observe any effect of recF on intrachromosomal recombination, although it did have an effect on the frequency of plasmid integration (Table 4). This discrepancy can be explained by the fact that we did not use DNA damaging agents in our study. These agents lead to single stranded stretches of DNA that represent substrates for recF (and recA). Our observation that recF did affect plasmid integration may reflect the presence of stretches of ssDNA in the plasmid, presumably due to supercoiling effects.
To induce strong primary and memory immune responses, Salmonella delivery vectors should be sufficiently invasive and persistent to allow antigen expression in targeting organs, while maintaining a high degree of safety. This requires the use of mutations that attenuate the Salmonella vector without impairing its antigen delivery ability. Many attenuating mutations impair invasion and colonization ability. In our study, we confirmed a previous report that recF is not required for S. Typhimurium virulence in mice , indicating that the recF mutant remains invasive and replicates well in colonized organs. Therefore, including a ΔrecF mutation in a Salmonella vaccine strain is unlikely to affect its immunogenicity. Our results with the S. Typhimurium ΔrecA strain are consistent with two previous, independent studies showing that recA mutations reduce Salmonella virulence [51, 52]. To evaluate the potential effect of ΔrecA mutation on immunogenicity, mice inoculated with the recA mutant were challenged with a lethal dose of virulent wild-type S. Typhimurium. All the challenged mice survived, indicating that a ΔrecA mutant retains immunogenicity and therefore may be suitable for use in a vaccine. However, since it does not affect virulence, inclusion of a ΔrecF mutation into a Salmonella vector that has been attenuated by other means to reduce the frequency of intra- and interplasmid recombination, may be more desirable than a ΔrecA mutation. Studies are currently underway to investigate these possibilities.
Our data show that ΔrecA and ΔrecF mutations resulted in reduced frequencies of intraplasmid recombination in all Salmonella strains tested, which included three serovars, when there was an intervening sequence between the direct duplications (Table 3). Our results also show that it is likely that deletions in recA, recF or recJ will not be useful for reducing interplasmid recombination in S. Typhi vaccine strains, since we did not observe any reduction in interplasmid recombination frequency. This result was disappointing, since the majority of human trials with live Salmonella vaccines have focused on S. Typhi. In the case of S. Typhi, it appears that the best approach to preventing interplasmid recombination will be in the careful design of each plasmid, avoiding any stretches of homology. However, for vaccines based on S. Typhimurium or S. Paratyphi A, introduction of a ΔrecF mutation into attenuated Salmonella vaccine strains carrying multiple plasmids is a useful approach to reduce unwanted plasmid/plasmid or plasmid/chromosome recombination without further attenuating the strain or negatively influencing its immunogenicity. The ΔrecA mutation had a similar or more pronounced effect on reducing various classes of recombination and it clearly had an effect on virulence. We did not examine the effect of a ΔrecA mutation on the immunogenicity of a vectored antigen. Based on its effect on virulence, it may affect the immunogenicity of the vectored antigen in some attenuation backgrounds and therefore may not be applicable for all attenuation strategies.
In this study we showed that ΔrecA and ΔrecF mutations reduce intraplasmid recombination in S. Typhimurium, S. Typhi and S. Paratyphi while there is an intervening sequence between the duplicated sequences. The ΔrecA and ΔrecF mutations reduce interplasmid recombination in S. Typhimurium and S. Paratyphi but not in S. Typhi. The ΔrecF mutations also sharply reduce intraplasmid recombination between direct duplications in S. Typhi. Since ΔrecA mutation results in an avirulent Salmonella strain, the ΔrecF mutation is ideal for reducing plasmid recombination in Salmonella delivery vectors without impairing the virulence. The intrachromosomal recombination and plasmid integration are 2-3 orders lower than plasmid recombination, therefore are less concerned. These information help develop Salmonella delivery vectors able to stably maintain plasmid cargoes for vaccine development and gene therapy.
Bacterial strains and media
E. coli K-12 strain EPI300™ was used for cloning and stable maintenance of plasmids. All Salmonella strains used in this work were derived from Salmonella enterica serovar Typhimurium wild-type (wt) strain χ3761 (UK-1), serovar Typhi strains Ty2 and ISP1820 or serovar Paratyphi A strain χ8387. Their origin and relevant genotypes are presented in Table 2. Bacteria were grown in LB broth .
Primers used in this study
To construct plasmid pYA4463 (Figure 1 panel A), a XbaI-HincII fragment containing the tetA promoter and 568 bp of the 5' end of tetA, was excised from pACYC184 and ligated into XbaI-EcoRV digested pACYC184.
To generate plasmid pYA4590 (Figure 1 panel A), the 5' end of tetA gene together with its promoter was amplified from pACYC184 with primers P1 and P2, which contain engineered XbaI and KpnI restriction sites, respectively. The resulting PCR fragment was digested with XbaI and KpnI. The kan gene was amplified from plasmid p15A-PB2-kan, a pACYC184 derivative carrying a influenza virus PB2 gene and a kan cassette, with primers P3 and P4, which were engineered to contain KpnI and BamHI sites, respectively. The resulting PCR fragment was digested with KpnI and BamHI. The two digested PCR fragments were ligated into pACYC184 digested with XbaI and BamHI. The resulting plasmid, pYA4590, contains the tetA promoter and 891 bp of the 5' end of tetA, a 1041-bp fragment encoding kan and its promoter followed by 902 bp of the 3'end of tetA.
To construct plasmid pYA4464 (Figure 1 panel B), plasmid pACYC184 was digested with XbaI and EcoRV to remove the 5' 102 bp of the tetA gene and the tetA promoter. The cohesive ends were filled using the Klenow large fragment of DNA polymerase and the linear plasmid was self-ligated to yield plasmid pYA4464.
To construct plasmid pYA4465 (Figure 1 panel B), the 5' 853 bp of tetA together with its promoter was amplified from pACYC184 using primers P5 and P6, which were engineered with SmaI and BglII sites, respectively. The resulting PCR fragment was digested with SmaI and BglII, and ligated to EcoRV and BglII digested pBAD-HisA.
Creation of recdeletions
The recA62 deletion, which deletes 1062 bp, encompassing the entire recA open reading frame, introduced into the bacterial chromosome using either λ Red recombinase-mediated recombination , or conjugation with E. coli strain χ7213(pYA4680) followed by selection/counterselection with chloramphenicol and sucrose, respectively . The cat-sacB cassette was amplified from plasmid pYA4373 by PCR with primers P7 and P8 to add flanking sequence. The PCR product was further amplified with primer P9 and P10 to extend the flanking sequence. Those two steps of amplification resulted in the cat-sacB cassette flanked by 100 bp of recA flanking sequences at both ends. The PCR product was purified with QIAquick Gel Extraction Kit (QIAGEN) and electroporated into Salmonella strains carrying plasmid pKD46 to facilitate replacement of the recA gene with the cat-sacB cassette. Electroporants containing the cat-sacB cassette were selected on LB plates containing 12.5 μg chloramphenicol ml-1. From S. Typhimurium chromosome, a 500-bp sequence upstream recA gene was amplified with primers P11 and primer P12 and a 500-bp sequence downstream recA gene was amplified with primers P13 and P14. Primers P12 and P13 were engineered with a KpnI site. The two PCR fragments were digested with KpnI, ligated and amplified with primers P11 and P14. The resulting PCR product was digested with isocaudarner SpeI and XbaI and ligated into XbaI-digested pRE112 to yield plasmid pYA4680. In addition, undigested, agarose-gel purified PCR product was electroporated into the cat-sacB Salmonella strains carrying plasmid pKD46 and spread onto LB plates containing 5% sucrose to select for deletion of the cat-sacB cassette. Chloramphenicol-sensitive isolates were verified as ΔrecA62 by PCR using primers P15 and P16 (ΔrecA62: 1360 bp; wt: 2412 bp). S. Typhimurium strains χ9833 and χ9939 were constructed by this method (Table 2). For construction of a ΔrecA62 mutant of S. Typhi, wild-type strain Ty2 was mated with E. coli strain χ7213(pYA4680). Transconjugants were selected on LB plates containing chloramphenicol, followed by counterselection on sucrose plates as described above. The resulting ΔrecA62 strain was designated χ11159. The S. Paratyphi A strain χ11243 was generated from wild-type strain χ8387 using the same strategy.
The ΔrecF deletion strains were constructed using suicide vectors pYA3886 and pYA4783. From the S. Typhimurium chromosome, a 397-bp sequence upstream of the recF gene was amplified with primers P17 and P18, which were engineered with XbaI and KpnI sites, respectively. The downstream 296-bp sequence (including 78 bp from the 3' ORF of recF) was amplified with primers P19 and P20 containing KpnI and SphI sites, respectively. The two fragments were digested and inserted into XbaI-SphI digested pRE112, resulting in plasmid pYA3886. The corresponding deletion was designated ΔrecF126. Strains χ9070, χ9081 and χ11244 were generated by conjugation using E. coli strain χ7213(pYA3886). Phage P22HTint mediated transduction was used to construct Typhi strain χ11053 . The ΔrecF126 deleted 996 bp from the 5'end of recF in serovars Typhimurium and Paratyphi. The upstream flanking sequence of S. Typhi is different with the other serotypes. To construct a serovar Typhi-specific ΔrecF mutation, we constructed a new suicide vector. The recF upstream flanking sequence in plasmid pYA3886 was replaced with the corresponding DNA sequence (447 bp) from S. Typhi Ty2. Primers P21 and P22 were used for this modification. The resulting plasmid was designated as pYA4783. The Typhi-specific ΔrecF1074 mutation was introduced into S. Typhi strains ISP1820 and Ty2 by conjugation with E. coli strain χ7213(pYA4783) to yield strains χ11133 and χ11134, respectively. Primers P23 and P24 were used to verify the recF126 and recF1074 deletions.
Similar strategies were used to construct the Δ recJ1315 deletion with suicide vector pYA3887. From the S. Typhimurium chromosome, 330 bp upstream of the recJ gene was amplified with primers P25 and P26, which were engineered with XbaI and KpnI sites, respectively. The 299-bp downstream sequence was amplified with primers P27 and P28, engineered with KpnI and SphI sites, respectively. The two fragments were digested and ligated with XbaI-SphI digested pRE112. The resulting plasmid was designated pYA3887 and the corresponding deletion was named ΔrecJ1315. Strains χ9072 and χ11245 were generated by conjugating the parental strains with E. coli strain χ7213(pYA3887). Strain χ11194 was constructed by phage P22HTint mediated transduction. The ΔrecJ1315 mutation is a deletion of the entire recJ gene (1734 bp). Primers P29 and P30 were used to verify the recJ1315 deletion (ΔrecJ1315: 736 bp; wt: 2461 bp).
To test chromosome-related recombination, the 5'tet and 3'tet fragments were inserted into the cysG gene of each S. Typhimurium strain using the λ Red system. The 460-bp fragment of the cysG gene was amplified using primers P31 and P32 that were engineered with HindIII and BglII sites, respectively. The PCR product was digested with HindIII and BglII. A 480 bp adjoining fragment of cysG was amplified with primers P33 and P34. Primer P33 was engineered with BglII and PstI sites and primer P34 was engineered with a SacI site. The PCR product was digested with BglII and SacI. The two digested PCR fragments were ligated into HindIII and SacI digested pYA4518, deleting green fluorescent protein (GFP) gene. The resulting plasmid pYA4518-cysG has BssHII and PstI sites between the two cysG-fragments. This plasmid was digested with BssHII, followed by treatment with the Klenow large fragment. The linear plasmid was further digested with PstI for insertion of truncated tetA genes. The 5'tet-kan-3'tet cassette was amplified from pYA4590 with primers P35 and P36. Primer P36 was engineered with a PstI site. The PCR product was digested with PstI and inserted between the cysG fragments in pYA4518-cysG to yield plasmid pYA4689. The 5'tet-kan cassette was amplified from pYA4590 with primers P35 and P37. Primer P37 was engineered with a PstI site. The PCR product was digested with PstI and inserted into treated pYA4518-cysG to obtain plasmid pYA4690. The 5'tet-kan-3'tet cassette, together with cysG flanking sequences, was amplified from pYA4689 using primers P31 and P34. The PCR product was electroporated into strains χ3761(pKD46), χ9070(pKD46), χ9072(pKD46) and χ9833(pKD46) with selection on LB plates containing 25 μg/ml chloramphenicol. After growth at 37°C to cure plasmid pKD46, the resulting strains containing chromosomal copies of the 5'tet-kan-3'tet cassette in cysG were designated χ9931 (Rec+), χ9932 (ΔrecF), χ9933 (ΔrecJ) and χ9934 (ΔrecA), respectively. Primers P38 and P39 were used to verify insertion in the cysG gene. The 5'tet-kan cassette together with cysG flanking sequences was amplified from pYA4690 with primers P31 and P34. Using the same strategy, the PCR product was electroporated into pKD46 transformants of strains χ3761, χ9070, χ9072 and χ9833 to yield strains χ9935 (Rec+), χ9936 (ΔrecF), χ9937 (ΔrecJ) and χ9938 (ΔrecA), respectively, each containing the 5'tet-kan cassette inserted into cysG. These strains were transformed with plasmid pYA4464 to test plasmid integration based on the 789-bp of tetA sequence common to both the plasmid and the bacterial chromosome.
Analysis of recombination frequency
To examine plasmid recombination and plasmid integration, plasmid(s) containing truncated tetA genes were introduced into Salmonella strains with or without rec mutations. The resulting strains were inoculated into 3 ml of LB broth supplemented with 100 μg/ml ampicillin and/or 25 μg/ml chloramphenicol, as needed. After 8 h growth at 37°C, bacteria were serially diluted in 10-fold steps. 100 μl of the 10-2, 10-3 or 10-4 dilution were spread onto LB-agar plates supplemented with 10 μg tetracycline ml-1 and 100 μl of the 10-5, 10-6 or 10-7 dilutions were spread onto LB-agar plates with or without the addition of antibiotics, as needed. Plates were incubated overnight at 37°C. The ratio of tetracycline resistant colonies to total colonies was calculated as the recombination frequency. The average mean frequency was calculated using the frequencies obtained from 3-10 assays for each strain. Following one-way ANOVA, the Dunnett's test was used to compare multiple groups against the control. The Student's t-test was used to analyze two independent samples.
Complementation of recmutation
Plasmid pYA5001 has a pSC101 ori, a gentamicin resistance marker and a prokaryotic green fluorescent protein (GFP) gene cassette flanked by two AhdI sites. A linearized T vector for cloning PCR products can be obtained by removing the GFP cassette by AhdI digestion. The recA genes from S. Typhimurium and S. Typhi were amplified using their respective chromosomal DNAs as template with primers P40 and P41. The recF genes were amplified similarly using primers P42 and P43. The forward primer P42 was engineered to include the S. Typhimurium lpp promoter sequence ttctcaacataaaaaagtttgtgtaatact (the -35 and -10 boxes are underlined). Amplified DNA fragment were treated with Taq DNA polymerase in the presence of dATP to add 3' A overhangs. Then the treated PCR products were cloned into pYA5001-derived T vector to yield recA plasmids pYA5002 (Typhimurium) and pYA5004 (Typhi), and recF plasmids pYA5005 (Typhimurium) and pYA5006 (Typhi). The recA plasmids, recF plasmids or empty vector plasmid pYA5001 were transformed into S. Typhimurium recA or recF mutants, respectively for complementation studies. The recA and recF plasmids were also introduced into Salmonella strains carrying pYA4590 or pYA4463 to complement the rec mutation and measure the plasmid recombination frequency.
UV sensitivity test
Quantitative UV killing curves were measured as described previously . Briefly, cells were grown in 3 ml of LB broth at 37°C with vigorous shaking to mid-log phase. The cells were then 10 fold serially diluted in buffered saline with gelatin (BSG) and spread on LB agar plates. Multiple dilutions were exposed to 254 nm UV in a dark room at each designated dose. Then the plates were wrapped with aluminum foil and placed at 37°C overnight. The 10-6 dilutions were not exposed to UV to determine the total bacterial cell numbers present in the culture. Surviving fractions were calculated as the CFU remaining after UV exposure/total CFU present.
Virulence determination of the recmutants
Eight-week old BALB/c female mice were purchased from Charles River Laboratories (Wilmington, MA). Mice were held in quarantine for 1 week before use in experiments. Food and water were deprived 6 h before administration of bacteria. Each mouse was orally inoculated with 20 μl of Salmonella suspended in buffered saline with gelatin (BSG) by pipet feeding. Food and water were returned 30 min after inoculation. All mice were observed for a month to record mortality. The 50% lethal dose (LD50) was determined via the Reed and Muench method . Surviving mice were challenged orally with wild-type Salmonella χ3761 two months after the first inoculation.
This work was supported by grants from the National Institutes of Health (AI065779) and the Bill & Melinda Gates Foundation (no. 37863).
- Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S: Duration of efficacy of Ty21a, attenuated Salmonella Typhi live oral vaccine. Vaccine. 1999, 17 (Suppl 2): S22-27. 10.1016/S0264-410X(99)00231-5.PubMedView ArticleGoogle Scholar
- Curtiss R: Bacterial infectious disease control by vaccine development. J Clin Invest. 2002, 110 (8): 1061-1066.PubMedPubMed CentralView ArticleGoogle Scholar
- Tacket CO, Levine MM: CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression. Clin Infect Dis. 2007, 45 (Suppl 1): S20-23. 10.1086/518135.PubMedView ArticleGoogle Scholar
- Lewis GK: Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?. Expert Rev Vaccines. 2007, 6 (3): 431-440. 10.1586/147605184.108.40.2061.PubMedView ArticleGoogle Scholar
- Darji A, Guzman CA, Gerstel B, Wachholz P, Timmis KN, Wehland J, Chakraborty T, Weiss S: Oral somatic transgene vaccination using attenuated S. Typhimurium. Cell. 1997, 91 (6): 765-775. 10.1016/S0092-8674(00)80465-1.PubMedView ArticleGoogle Scholar
- Mollenkopf H, Dietrich G, Kaufmann SH: Intracellular bacteria as targets and carriers for vaccination. Biol Chem. 2001, 382 (4): 521-532. 10.1515/BC.2001.066.PubMedView ArticleGoogle Scholar
- Cheminay C, Hensel M: Rational design of Salmonella recombinant vaccines. Int J Med Microbiol. 2008, 298 (1-2): 87-98. 10.1016/j.ijmm.2007.08.006.PubMedView ArticleGoogle Scholar
- Kwon YM, Cox MM, Calhoun LN: Salmonella-based vaccines for infectious diseases. Expert Rev Vaccines. 2007, 6 (2): 147-152. 10.1586/147605220.127.116.11.PubMedView ArticleGoogle Scholar
- Schoen C, Stritzker J, Goebel W, Pilgrim S: Bacteria as DNA vaccine carriers for genetic immunization. Int J Med Microbiol. 2004, 294 (5): 319-335. 10.1016/j.ijmm.2004.03.001.PubMedView ArticleGoogle Scholar
- Vassaux G, Nitcheu J, Jezzard S, Lemoine NR: Bacterial gene therapy strategies. J Pathol. 2006, 208 (2): 290-298. 10.1002/path.1865.PubMedView ArticleGoogle Scholar
- Moreno M, Kramer MG, Yim L, Chabalgoity JA: Salmonella as live trojan horse for vaccine development and cancer gene therapy. Curr Gene Ther. 2010, 10 (1): 56-76. 10.2174/156652310790945566.PubMedView ArticleGoogle Scholar
- Zhang L, Gao L, Zhao L, Guo B, Ji K, Tian Y, Wang J, Yu H, Hu J, Kalvakolanu DV, et al: Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar Typhimurium carrying plasmid-based small interfering RNAs. Cancer Res. 2007, 67 (12): 5859-5864. 10.1158/0008-5472.CAN-07-0098.PubMedView ArticleGoogle Scholar
- Bai Y, Li H, Vu GP, Gong H, Umamoto S, Zhou T, Lu S, Liu F: Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells. Proc Natl Acad Sci USA. 2010, 107 (16): 7269-7274. 10.1073/pnas.0912813107.PubMedPubMed CentralView ArticleGoogle Scholar
- Cicin-Sain L, Brune W, Bubic I, Jonjic S, Koszinowski UH: Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. J Virol. 2003, 77 (15): 8249-8255. 10.1128/JVI.77.15.8249-8255.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Curtiss R: Antigen delivery systems: Development of live recombinant attenuated bacterial antigen and DNA vaccine delivery vector vaccines. Mucosal Immunology. Edited by: Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer L. 2005, San Diego: Elsevier Academic Press, 1009-1037. full_text.View ArticleGoogle Scholar
- Luo Y, Zhou H, Mizutani M, Mizutani N, Reisfeld RA, Xiang R: Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine. Proc Natl Acad Sci USA. 2003, 100 (15): 8850-8855. 10.1073/pnas.1033132100.PubMedPubMed CentralView ArticleGoogle Scholar
- Zhang X, Kong W, Ashraf S, Curtiss R: A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine. J Virol. 2009, 83 (18): 9296-9303. 10.1128/JVI.00781-09.PubMedPubMed CentralView ArticleGoogle Scholar
- Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda SY, Roland KL, Curtiss R: Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci USA. 2009, 106 (2): 593-598. 10.1073/pnas.0811697106.PubMedPubMed CentralView ArticleGoogle Scholar
- Curtiss R, Wanda SY, Gunn BM, Zhang X, Tinge SA, Ananthnarayan V, Mo H, Wang S, Kong W: Salmonella enterica serovar Typhimurium strains with regulated delayed attenuation in vivo. Infect Immun. 2009, 77 (3): 1071-1082. 10.1128/IAI.00693-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Konjufca V, Jenkins M, Wang S, Juarez-Rodriguez MD, Curtiss R: Immunogenicity of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine strains carrying a gene that encodes Eimeria tenella antigen SO7. Infect Immun. 2008, 76 (12): 5745-5753. 10.1128/IAI.00897-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Xin W, Wanda SY, Li Y, Wang S, Mo H, Curtiss R: Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun. 2008, 76 (7): 3241-3254. 10.1128/IAI.01623-07.PubMedPubMed CentralView ArticleGoogle Scholar
- Wang S, Li Y, Scarpellini G, Kong W, Shi H, Baek CH, Gunn B, Wanda SY, Roland KL, Zhang X, et al: Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect Immun. 2010, 78 (9): 3969-3980. 10.1128/IAI.00444-10.PubMedPubMed CentralView ArticleGoogle Scholar
- Kong W, Wanda SY, Zhang X, Bollen W, Tinge SA, Roland KL, Curtiss R: Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci USA. 2008, 105 (27): 9361-9366. 10.1073/pnas.0803801105.PubMedPubMed CentralView ArticleGoogle Scholar
- Ameiss K, Ashraf S, Kong W, Pekosz A, Wu WH, Milich D, Billaud JN, Curtiss R: Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype. Vaccine. 28 (41): 6704-6713. 10.1016/j.vaccine.2010.07.083.
- Laban A, Cohen A: Interplasmidic and intraplasmidic recombination in Escherichia coli K12. Mol Gen Genet. 1981, 184 (2): 200-207.PubMedGoogle Scholar
- Cohen A, Laban A: Plasmidic recombination in Escherichia coli K12: the role of recF gene function. Mol Gen Genet. 1983, 189 (3): 471-474. 10.1007/BF00325911.PubMedView ArticleGoogle Scholar
- Fishel RA, James AA, Kolodner R: recA-independent general genetic recombination of plasmids. Nature. 1981, 294 (5837): 184-186. 10.1038/294184a0.PubMedView ArticleGoogle Scholar
- Matfield M, Badawi R, Brammar WJ: Rec-dependent and Rec-independent recombination of plasmid-borne duplications in Escherichia coli K12. Mol Gen Genet. 1985, 199 (3): 518-523. 10.1007/BF00330768.PubMedView ArticleGoogle Scholar
- James AA, Morrison PT, Kolodner R: Genetic recombination of bacterial plasmid DNA. Analysis of the effect of recombination-deficient mutations on plasmid recombination. J Mol Biol. 1982, 160 (3): 411-430. 10.1016/0022-2836(82)90305-9.PubMedView ArticleGoogle Scholar
- Kolodner R, Fishel RA, Howard M: Genetic recombination of bacterial plasmid DNA: effect of RecF pathway mutations on plasmid recombination in Escherichia coli. J Bacteriol. 1985, 163 (3): 1060-1066.PubMedPubMed CentralGoogle Scholar
- Smith GR: Homologous recombination in procaryotes. Microbiol Rev. 1988, 52 (1): 1-28.PubMedPubMed CentralGoogle Scholar
- Kolodner R, Fishel RA, Howard M: Genetic recombination of bacterial plasmid DNA: effect of RecF pathway mutations on plasmid recombination in Escherichia coli. J Bacterio. 1985, 163 (3): 1060-1066.Google Scholar
- Cox MM: A broadening view of recombinational DNA repair in bacteria. Genes Cells. 1998, 3 (2): 65-78. 10.1046/j.1365-2443.1998.00175.x.PubMedView ArticleGoogle Scholar
- McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, et al: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001, 413 (6858): 852-856. 10.1038/35101614.PubMedView ArticleGoogle Scholar
- Bi X, Liu LF: recA-independent and recA-dependent intramolecular plasmid recombination. Differential homology requirement and distance effect. J Mol Biol. 1994, 235 (2): 414-423. 10.1006/jmbi.1994.1002.PubMedView ArticleGoogle Scholar
- Kato T, Rothman RH, Clark AJ: Analysis of the role of recombination and repair in mutagenesis of Escherichia coli by UV irradiation. Genetics. 1977, 87 (1): 1-18.PubMedPubMed CentralGoogle Scholar
- Mahan MJ, Casadesus J, Roth JR: The Salmonella Typhimurium RecJ function permits growth of P22 abc phage on recBCD+ hosts. Mol Gen Genet. 1992, 232 (3): 470-478. 10.1007/BF00266252.PubMedView ArticleGoogle Scholar
- Clark AJ: rec genes and homologous recombination proteins in Escherichia coli. Biochimie. 1991, 73 (4): 523-532. 10.1016/0300-9084(91)90124-J.PubMedView ArticleGoogle Scholar
- Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM: Biochemistry of homologous recombination in Escherichia coli. Microbiol Rev. 1994, 58 (3): 401-465.PubMedPubMed CentralGoogle Scholar
- Zaman MM, Boles TC: Plasmid recombination by the RecBCD pathway of Escherichia coli. J Bacteriol. 1996, 178 (13): 3840-3845.PubMedPubMed CentralGoogle Scholar
- Persky NS, Lovett ST: Mechanisms of recombination: lessons from E. coli. Crit Rev Biochem Mol Biol. 2008, 43 (6): 347-370. 10.1080/10409230802485358.PubMedView ArticleGoogle Scholar
- Webb BL, Cox MM, Inman RB: Recombinational DNA repair: the RecF and RecR proteins limit the extension of RecA filaments beyond single-strand DNA gaps. Cell. 1997, 91 (3): 347-356. 10.1016/S0092-8674(00)80418-3.PubMedView ArticleGoogle Scholar
- Morimatsu K, Kowalczykowski SC: RecFOR proteins load RecA protein onto gapped DNA to accelerate DNA strand exchange: a universal step of recombinational repair. Mol Cell. 2003, 11 (5): 1337-1347. 10.1016/S1097-2765(03)00188-6.PubMedView ArticleGoogle Scholar
- Lusetti SL, Cox MM: The bacterial RecA protein and the recombinational DNA repair of stalled replication forks. Annu Rev Biochem. 2002, 71: 71-100. 10.1146/annurev.biochem.71.083101.133940.PubMedView ArticleGoogle Scholar
- Levine MM, Tacket CO, Sztein MB: Host-Salmonella interaction: human trials. Microbes Infect. 2001, 3 (14-15): 1271-1279. 10.1016/S1286-4579(01)01487-3.PubMedView ArticleGoogle Scholar
- Tacket CO, Hone DM, Curtiss R, Kelly SM, Losonsky G, Guers L, Harris AM, Edelman R, Levine MM: Comparison of the safety and immunogenicity of ΔaroC ΔaroD and Δcya Δcrp Salmonella Typhi strains in adult volunteers. Infect Immun. 1992, 60 (2): 536-541.PubMedPubMed CentralGoogle Scholar
- Frey SE, Bollen W, Sizemore D, Campbell M, Curtiss R: Bacteremia associated with live attenuated χ8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers. Clin Immunol. 2001, 101 (1): 32-37. 10.1006/clim.2001.5088.PubMedView ArticleGoogle Scholar
- McClelland M, Sanderson KE, Clifton SW, Latreille P, Porwollik S, Sabo A, Meyer R, Bieri T, Ozersky P, McLellan M, et al: Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet. 2004, 36 (12): 1268-1274. 10.1038/ng1470.PubMedView ArticleGoogle Scholar
- Deng W, Liou SR, Plunkett G, Mayhew GF, Rose DJ, Burland V, Kodoyianni V, Schwartz DC, Blattner FR: Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol. 2003, 185 (7): 2330-2337. 10.1128/JB.185.7.2330-2337.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Espinosa-Aguirre J, Barajas-Lemus C, Hernandez-Ojeda S, Govezensky T, Rubio J, Camacho-Carranza R: RecBCD and RecFOR dependent induction of chromosomal deletions by sodium selenite in Salmonella. Mutat Res. 2009, 665 (1-2): 14-19.PubMedView ArticleGoogle Scholar
- Cano DA, Pucciarelli MG, Garcia-del Portillo F, Casadesus J: Role of the RecBCD recombination pathway in Salmonella virulence. J Bacteriol. 2002, 184 (2): 592-595. 10.1128/JB.184.2.592-595.2002.PubMedPubMed CentralView ArticleGoogle Scholar
- Buchmeier NA, Lipps CJ, So MY, Heffron F: Recombination-deficient mutants of Salmonella Typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Mol Microbiol. 1993, 7 (6): 933-936. 10.1111/j.1365-2958.1993.tb01184.x.PubMedView ArticleGoogle Scholar
- Bertani G: Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol. 1951, 62 (3): 293-300.PubMedPubMed CentralGoogle Scholar
- Sun W, Wang S, Curtiss R: Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome. Appl Environ Microbiol. 2008, 74 (13): 4241-4245. 10.1128/AEM.00940-08.PubMedPubMed CentralView ArticleGoogle Scholar
- Roland K, Curtiss R, Sizemore D: Construction and evaluation of a Δcya Δcrp Salmonella Typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 1999, 43 (3): 429-441. 10.2307/1592640.PubMedView ArticleGoogle Scholar
- Kang HY, Dozois CM, Tinge SA, Lee TH, Curtiss R: Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors. J Bacteriol. 2002, 184 (1): 307-312. 10.1128/JB.184.1.307-312.2002.PubMedPubMed CentralView ArticleGoogle Scholar
- Knudson GB: Photoreactivation of UV-irradiated Legionella pneumophila and other Legionella species. Appl Environ Microbiol. 1985, 49 (4): 975-980.PubMedPubMed CentralGoogle Scholar
- Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg. 1937, 27 (3): 493-497.Google Scholar
- Chang AC, Cohen SN: Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol. 1978, 134 (3): 1141-1156.PubMedPubMed CentralGoogle Scholar
- Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K12 using PCR products. Proc Natl Acad Sci USA. 2000, 97 (12): 6640-6645. 10.1073/pnas.120163297.PubMedPubMed CentralView ArticleGoogle Scholar
- Edwards RA, Keller LH, Schifferli DM: Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene. 1998, 207 (2): 149-157. 10.1016/S0378-1119(97)00619-7.PubMedView ArticleGoogle Scholar
- Zhang X, Kelly SM, Bollen WS, Curtiss R: Characterization and immunogenicity of Salmonella Typhimurium SL1344 and UK-1 Δcrp and Δcdt deletion mutants. Infect Immun. 1997, 65 (12): 5381-5387.PubMedPubMed CentralGoogle Scholar
- Santander J, Wanda SY, Nickerson CA, Curtiss R: Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi. Infect Immun. 2007, 75 (3): 1382-1392. 10.1128/IAI.00888-06.PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.